We are live on ! Find out more
ST

Skorpios Trust Portfolio holdings

AUM $53.2M
1-Year Est. Return 90.96%
This Fund
S&P 500
This Quarter Est. Return
-62.83%
1 Year Est. Return
+90.96%
3 Year Est. Return
+173.58%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$57M
AUM Growth
-$173M
Cap. Flow
-$76.6M
Cap. Flow %
-134.37%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
2
Avg Time Held
7 quarters
Top 10 Avg Time Held
7 quarters
Top 20 Avg Time Held
7 quarters

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AKRO icon
Akero Therapeutics
AKRO
+$75.7M
2
ATVI
Activision Blizzard
ATVI
+$910K

Sector Composition

Rank Sector Weight
1 Healthcare 99.78%
2 Miscellaneous 0.22%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
STOK icon
1
Stoke Therapeutics
STOK
$1.56B
$56.9M 99.78%
14,443,681
– –
2021 Q4
7 quarters
XBI icon
2
State Street SPDR S&P Biotech ETF
XBI
$10B
$123K 0.22%
1,686
– –
2021 Q4
7 quarters
AKRO icon
3
DELISTED
Akero Therapeutics
AKRO
– –
-1,621,829
Closed -$75.7M –
ATVI
4
DELISTED
Activision Blizzard
ATVI
– –
-10,800
Closed -$910K –

Similar funds

ACM
Aurelius Capital Management New York $55.2M AUM 124.79% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
CCCPV
Castle Creek Capital Partners VI San Diego, California $55.9M AUM 7.91% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
NCFG
New Century Financial Group Princeton, New Jersey $56.3M AUM 16.99% 1-Year Est. Return
E
EnerVest Houston, Texas $50.1M AUM 2.25% 1-Year Est. Return
RPM
Ridgemont Partners Management Charlotte, North Carolina $49.7M AUM 26.51% 1-Year Est. Return
ECT
Ebor Charitable Trust Jackson, Wyoming $49.4M AUM 13.04% 1-Year Est. Return

Skorpios Trust's Q3 2023 Portfolio in Review

As of Q3 2023, Skorpios Trust held 4 positions worth $57M, down 75% from $230M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Skorpios Trust withdrew a net $76.6M in Q3 2023, closing 2 positions. Its most notable exit was Akero Therapeutics, an estimated $75.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Miscellaneous and Technology.

  • Skorpios Trust fully exited Akero Therapeutics in Q3 2023, selling an estimated $75.7M.
  • Skorpios Trust's ten largest holdings make up 100% of its $57M portfolio in Q3 2023.
  • Skorpios Trust opened 0 new positions and closed 2 in Q3 2023.
  • Skorpios Trust's portfolio value fell 75% quarter-over-quarter to $57M.

Based on Skorpios Trust's 13F filing for Q3 2023, filed 6 Nov 2023.